Pharmacyclics, Inc. is a pharmaceutical company developing therapeutic products in oncology and immune mediated diseases based on targets, pathways and mechanisms. The Company's pharmaceutical agents are synthetic small molecules designed to target key biochemical pathways in diseased cells. Its late-stage product candidate, motexafin gadolinium (MGd, formerly Xcytrin) has completed Phase 3 trials in patients with brain metastases from non-small-cell lung cancer (NSCLC) and is in two Phase 2 trials. The Company has three other drug candidates with product development programs in late-stage, pre-clinical ...


There are no scholarships at this time


There are no events at this time

Company Data on Pharmacyclics
provided by Owler


Pharmacyclics is hiring for these positions

Show me: All available jobs